Press releases

3 March, 2025

Regulatory

Delisting of the shares of Abliva: last day of trading 17 March 2025

In accordance with Nasdaq Stockholm AB’s decision, following an application from the Board of Directors of Abliva AB (publ), the shares of Abliva will be delisted from Nasdaq Stockholm. The [&he ...

26 February, 2025

Regulatory

Notice of Extraordinary General Meeting in Abliva AB (publ)

At the request of Pharming Technologies B.V. (“Pharming”), a wholly-owned subsidiary of Pharming Group N.V., which, following its public offer to the shareholders of Abliva AB (publ) (“Abliva”), holds ...

25 February, 2025

Regulatory

Abliva applies for delisting and will convene an extraordinary general meeting

The outcome of the extended acceptance period in the public offer from Pharming Technologies B.V. (“Pharming”), a wholly-owned subsidiary of Pharming Group N.V., regarding Abliva AB (publ) ...

21 February, 2025

Regulatory

Abliva AB Year-End Report January – December 2024

Positive Interim Analysis of the FALCON Study